Associate Professor Anna Hearps
Co-Program Director, Disease Elimination; Head, Infection, Inflammation and Innate Immunity
Working groups
Burnet publications
View 66 moreThe Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier
American Journal of Reproductive Immunology
Brianna Jesaveluk et al
Characterisation of vaginal Lactobacillus isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiome
bioRxiv (Cold Spring Harbor Laboratory)
Jenna M. Wilson et al
Utility of longitudinal assessment of plasma biomarkers to predict cardiovascular disease in people with HIV
HIV Research & Clinical Practice
Janine M. Trevillyan et al
Reports and other work
-
Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity.
Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity.
Current projects
View 10 more
Methamphetamine and injecting drug use cohort studies: MIXMAX
MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.
Injecting drug use in Melbourne: SuperMIX cohort study
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).
Immunotherapy-based approaches to cure HIV
The objectives of this project include identifying the relevant NK subset which is the most potent killer of HIV-infected cells and developing anti-HIV antibodies with enhanced function.
